MoneyWorks4Me

Sunil Healthcare - Quaterly Results

14 Feb 2024 Evaluate
Net sales declined -11.66%  to  Rs. 226.69 million from Rs. 256.61 millions.The Net Loss for the quarter ended December 2023 is Rs. -3.69 millions as compared to Net Profit of Rs. 3.14 millions of corresponding quarter ended December 2022Operating profit for the quarter ended December 2023 decreased to 23.32 millions as compared to 32.51 millions of corresponding quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 226.69 256.61 -11.66 683.77 915.22 -25.29 1118.30 1163.73 -3.90
Other Income 29.75 2.38 1150.00 41.22 11.49 258.75 16.29 15.54 4.83
PBIDT 23.32 32.51 -28.27 57.40 177.60 -67.68 209.37 193.66 8.11
Interest 14.38 10.75 33.77 40.16 29.94 34.13 41.68 34.89 19.46
PBDT 8.94 21.76 -58.92 17.24 147.66 -88.32 167.69 158.77 5.62
Depreciation 14.54 16.73 -13.09 46.55 50.12 -7.12 70.10 63.06 11.16
PBT -5.60 5.03 -211.33 -29.31 97.54 -130.05 97.59 95.71 1.96
TAX -1.91 1.89 -201.06 -7.87 27.24 -128.89 27.82 27.95 -0.47
Deferred Tax -2.84 0.99 -386.87 -8.80 9.77 -190.07 11.07 12.80 -13.52
PAT -3.69 3.14 -217.52 -21.44 70.30 -130.50 69.77 67.76 2.97
Equity 102.55 102.55 0.00 102.55 102.55 0.00 102.55 102.55 0.00
PBIDTM(%) 10.29 12.67 -18.80 8.39 19.41 -56.74 18.72 16.64 12.50
Peers
Company Name CMP
Godrej Industries 1087.70
SRF 2493.00
BASF India 3512.00
Pidilite Inds. 1490.15
Tata Chemicals 654.80
View more..